IGF1 and hyperinsulinism: Insulin resistance, hyperinsulinemia, type 2 diabetes, and polycystic ovarian syndrome (PCOS) are known to promote endometrial proliferation by reducing the levels of sex hormone binding globulin and insulin-like growth factor 1 (IGF-1) binding proteins.